468P Osimertinib in patients with T790M mutation positive...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

468P Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data

Ahn, M-J., Lee, J-S., Han, J-Y., Kim, D-W., Cho, B.C., Kang, J.H., Kim, S-W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.032
Date:
December, 2016
File:
PDF, 45 KB
2016
Conversion to is in progress
Conversion to is failed